tradingkey.logo

Waters Corp

WAT
381.290USD
+4.460+1.18%
Close 02/06, 16:00ETQuotes delayed by 15 min
22.70BMarket Cap
34.94P/E TTM

Waters Corp

381.290
+4.460+1.18%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Waters Corp

Currency: USD Updated: 2026-02-06

Key Insights

Waters Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 21 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 414.62.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Waters Corp's Score

Industry at a Glance

Industry Ranking
21 / 205
Overall Ranking
101 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Waters Corp Highlights

StrengthsRisks
Waters Corporation offers analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences. The Company's segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates directly in over 35 countries and has products available in more than 100 countries.
Overvalued
The company’s latest PE is 34.94, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 59.37M shares, decreasing 4.01% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 411.00 shares of this stock.

Analyst Rating

Based on 21 analysts
Buy
Current Rating
414.622
Target Price
+7.88%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Waters Corp is 8.13, ranking 55 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 799.89M, representing a year-over-year increase of 8.05%, while its net profit experienced a year-over-year increase of 7.79%.

Score

Industry at a Glance

Previous score
8.13
Change
0

Financials

9.35

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.03

Operational Efficiency

7.90

Growth Potential

8.97

Shareholder Returns

7.38

Waters Corp's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Waters Corp is 6.79, ranking 148 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 34.94, which is 11.10% below the recent high of 38.82 and 38.56% above the recent low of 21.46.

Score

Industry at a Glance

Previous score
6.79
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 21/205
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Waters Corp is 7.62, ranking 122 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 395.00, with a high of 460.00 and a low of 351.43.

Score

Industry at a Glance

Previous score
7.62
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 21 analysts
Buy
Current Rating
414.622
Target Price
+7.88%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Waters Corp
WAT
21
Intuitive Surgical Inc
ISRG
36
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Waters Corp is 7.19, ranking 45 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 399.65 and the support level at 365.03, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.99
Change
0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(4)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-2.454
Sell
RSI(14)
46.695
Neutral
STOCH(KDJ)(9,3,3)
47.434
Buy
ATR(14)
10.855
Low Volatility
CCI(14)
-61.112
Neutral
Williams %R
58.299
Sell
TRIX(12,20)
-0.111
Sell
StochRSI(14)
70.209
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
380.154
Buy
MA10
381.269
Buy
MA20
387.280
Sell
MA50
389.246
Sell
MA100
365.454
Buy
MA200
344.758
Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Waters Corp is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 99.73%, representing a quarter-over-quarter increase of 2.14%. The largest institutional shareholder is The Vanguard, holding a total of 7.44M shares, representing 12.50% of shares outstanding, with 2.65% increase in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
7.63M
+3.33%
Fundsmith LLP
3.96M
+9.62%
BlackRock Institutional Trust Company, N.A.
3.81M
+0.26%
State Street Investment Management (US)
2.68M
+0.12%
MFS Investment Management
2.52M
+42.19%
AllianceBernstein L.P.
2.08M
-48.17%
Geode Capital Management, L.L.C.
1.58M
+2.09%
Mawer Investment Management Ltd.
1.55M
+225.46%
Invesco Capital Management LLC
Star Investors
1.36M
+54.22%
Fundsmith Investment Services Ltd.
1.36M
+11.10%
1
2

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Waters Corp is 8.93, ranking 15 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.17. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
8.93
Change
0
Beta vs S&P 500 index
1.16
VaR
+2.95%
240-Day Maximum Drawdown
+29.33%
240-Day Volatility
+37.61%

Return

Best Daily Return
60 days
+4.06%
120 days
+6.67%
5 years
+19.84%
Worst Daily Return
60 days
-2.56%
120 days
-2.86%
5 years
-13.81%
Sharpe Ratio
60 days
+0.57
120 days
+2.07
5 years
+0.31

Risk Assessment

Maximum Drawdown
240 days
+29.33%
3 years
+33.45%
5 years
+44.27%
Return-to-Drawdown Ratio
240 days
+0.02
3 years
+0.27
5 years
+0.12
Skewness
240 days
-0.58
3 years
+0.84
5 years
+0.59

Volatility

Realised Volatility
240 days
+37.61%
5 years
+33.09%
Standardised True Range
240 days
+2.86%
5 years
+2.41%
Downside Risk-Adjusted Return
120 days
+459.25%
240 days
+459.25%
Maximum Daily Upside Volatility
60 days
+18.70%
Maximum Daily Downside Volatility
60 days
+15.97%

Liquidity

Average Turnover Rate
60 days
+1.31%
120 days
+1.12%
5 years
--
Turnover Deviation
20 days
+38.79%
60 days
+51.75%
120 days
+29.38%

Peer Comparison

Healthcare Equipment & Supplies
Waters Corp
Waters Corp
WAT
7.91 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Becton Dickinson and Co
Becton Dickinson and Co
BDX
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Align Technology Inc
Align Technology Inc
ALGN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI